About Raymond Kelleher
Form D filings for Garuda Therapeutics from 2023 to 2024 list Raymond Kelleher as director.
Raymond Kelleher first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Raymond Kelleher in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Raymond Kelleher works with at each company, as listed on that company's latest Form D.
Garuda Therapeutics, Inc. · Form D, Oct 31, 2024
GM
Geoff Meyerson
Director
EA
Eric Aguiar
Director
SL
Steve Liapis
Director
RS
Rahul Singhvi
Director
DK
David Kirske
Executive officer
CG
Carl Gordon
Director
AC
Adam Craig
President and CEO, director